Cargando...
Treatment options for patients with HR+/HER2− advanced breast cancer during the COVID-19 pandemic: dose reduction of ribociclib does not diminish efficacy
Gardado en:
| Publicado en: | Breast Cancer Res Treat |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer US
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7239505/ https://ncbi.nlm.nih.gov/pubmed/32436148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05674-7 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|